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Abstract
Background: Adenosine deaminase (ADA) is useful in the diagnosis of tuberculous pleural effusion (TPE). This study
aims to determine the factors affecting pleural fluid ADA levels and to establish the optimal ADA levels for
diagnosis of TPE for different age groups.
Methods: This was a retrospective study from January 2007 to October 2011. One hundred and sixty patients who
had pleural fluid ADA performed for investigation of pleural effusion were analyzed. Variables examined included
demographics, pleural fluid characteristics and peripheral blood counts. The ADA cut-offs according to age were
selected using the receiver operating characteristic (ROC) curve.
Results: The mean pleural fluid ADA was significantly higher in the TPE group (100 ± 35 IU/L) compared to non TPE
patients (30 ± 37 IU/L). There was significant correlation between pleural fluid ADA and age, pleural fluid protein, LDH, and
fluid absolute lymphocyte count. The strongest correlation was seen with age (r = −0.621). For patients ≤ 55 years old the
ROC for ADA had area under curve (AUC) of 0.887. A pleural fluid ADA of 72 IU/L had sensitivity of 95.1%, specificity of
87.5%, positive predictive value (PPV) of 95.1% and negative predictive value (NPV) of 87.5% for the diagnosis of TPE. For
patients > 55 years old the AUC is 0.959. ADA of 26 IU/L had a sensitivity of 94.7%, specificity of 80.4%, PPV of 62% and
NPV of 97.8%.
Conclusions: There is a significant negative correlation between pleural fluid ADA and age. For older patients, a lower
ADA cut-off should be used to exclude TPE.
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Background
Pleural effusion is a common medical condition with many
possible underlying etiologies. Neutrophilic predominant
exudative effusions are due to acute processes e.g. pneumo-
nia or acute pulmonary embolism [1] whereas lymphocytic
effusions have a much longer list of differential diagnoses
[2]. However, in areas with high incidence of tuberculosis
(TB), pleural tuberculosis and malignancy are the most
likely cause of a lymphocytic pleural effusion [3,4].
Pleural fluid analysis and closed pleural biopsy are in-
tegral parts in the investigative work up of an exudative
pleural effusion. For diagnosis of tuberculous pleural effu-
sion (TPE), the yield of pleural fluid culture for mycobac-
teria is low at about 36% [5]. Joint sensitivity of biopsy
tissue samples is as high as 90% [5], but closed pleural bi-
opsy is a relatively invasive procedure and involves a long
waiting time for mycobacteria culture results. Pleural fluid
adenosine deaminase (ADA) has thus become an import-
ant diagnostic tool in the evaluation of exudative pleural
effusions because it is inexpensive, rapid and has a high ac-
curacy with sensitivity and specificity of up to 100% and
95% respectively for diagnosis of TPE [6].
Adenosine deaminase (ADA) is an enzyme which cataly-
ses the conversion of adenosine to inosine and plays an
important role in the differentiation of lymphoid cells. Its
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activity is high in diseases in which cellular immunity is
stimulated [1]. Different cut off values of ADA ranging
from 30–100 IU/L have been used in various studies, with
differing sensitivities and specificities [7]. The discrepan-
cies in the results can be due to different methods of ADA
analysis, prevalence of TB in various study populations as
well as differences in study population characteristics. Pre-
vious studies have demonstrated correlation between
pleural ADA level and CD4 lymphocyte counts [8], as well
as lower mean ADA level in Japanese patients with TPE
[9]. This suggests that patient immune status as well as
demographic factors may affect pleural fluid ADA levels.
However, few studies have looked into factors which can
affect pleural fluid ADA levels.
Our study therefore aims to:
a) Determine whether certain patient demographic
characteristics, pleural fluid biochemistry and
peripheral blood leucocyte counts affect pleural fluid
ADA level.
b) Establish ADA cut off value for diagnosis of TPE in
our study population.
If pleural fluid ADA does correlate significantly with the
variables studied, ADA value for patients should then be
interpreted based on patient demographics and relevant
laboratory investigations.
Methods
This was a retrospective study of the medical records of
patients investigated for pleural effusion in our hospital
from January 2007 to October 2011. The study design
was approved by the Institutional Review Board (IRB)
and exempted from further IRB review. Based on labora-
tory records a list of consecutive patients with pleural
fluid ADA sent was obtained. We felt that this was a re-
liable way of obtaining the list of patients investigated
for pleural effusion as pleural fluid ADA is routinely sent in
our institution for all cases of pleural effusion. Pleural fluid
ADA was measured by the spectrophotometric method de-
scribed by Giusti and Galanti. 80 patients with TPE were
identified. Another 80 patients with diagnoses other than
TPE were randomly selected using a random number
generator.
Pleural effusions were diagnosed to be due to pleural
TB (TPE) if: (i) pleural fluid smear was positive for acid
fast bacilli or fluid culture was positive for mycobacteria
tuberculosis; (ii) pleural biopsy histology showed granu-
lomas with no other causes of granulomatous lung disease;
(iii) pleural biopsy culture positive for mycobacteria tuber-
culosis; (iv) sputum culture positive for mycobacteria tu-
berculosis. Malignant pleural effusions were confirmed by
positive pleural fluid cytology or pleural biopsy histology
(closed biopsy or medical thoracoscopically obtained).
Parapneumonic effusions were diagnosed based on clinical
and radiographic features that were consistent with an
acute pulmonary infection and exclusion of other causes
of pleural effusion. Effusions were attributed to congestive
cardiac failure (CCF) if the effusion was a transudate with
consistent clinical features. An effusion was considered
to be lymphocyte-predominant if pleural fluid lympho-
cyte count was > 0.5 of total fluid leucocyte count, and
neutrophil-predominant if pleural fluid neutrophil count
was > 0.5 of total leucocyte count. Peripheral blood counts
used for analysis were most recent to the date of pleural
fluid investigations.
Continuous variables are expressed as mean ( SD) while
categorical variables are expressed as number and group
percentages. Differences in ADA levels between groups
were analysed using unpaired Student t test and one way
Anova. Correlation between ADA and specified variables
was quantified using Pearson correlation coefficient. This
was performed for the whole study population (n = 160)
as well as individually for the TPE and non TPE groups. A
correlation coefficient (r) of < 0.3 was considered to be
negligible correlation, r 0.3-0.5 was considered weak cor-
relation, r 0.5-0.7 was considered moderate correlation, r
0.7-0.9 was high correlation and r > 0.9 was very high cor-
relation. The best cut off value of ADA for diagnosis of
TPE was selected by receiver operating characteristics
(ROC) curve. We also fitted a multivariate linear regression
model and included all variables identified to be statistically
significant to see which ones remain independently associ-
ated with ADA level. All statistical analyses were per-
formed using IBM SPSS Statistics version 19. A 2 tailed p
value of < 0.05 was taken to be statistically significant.
Results
A total of 160 patients were investigated in this study.
The baseline characteristics of these patients are shown
in Table 1. 80 (50%) patients were diagnosed with TPE,
23 (14.4%) had malignant effusions, 40 (25%) had para-
pneumonic effusions, and 17 (10.6%) had effusions which
were classified as ‘Others’. Of the 17 cases, 14 were attrib-
uted to congestive cardiac failure and 3 were undeter-
mined. The 3 patients with undetermined effusions were
followed up for up to one year on hospital discharge. 2
had complete resolution of the effusion with no recur-
rence whereas the third had residual pleural effusion but
declined further investigations. Most of the patients were
male (73.1%) and Chinese (64.4%). The mean age of the
study population was 55 ± 21 yrs. The subgroup of TPE
patients had a lower mean age with the majority (76.3%)
age 55 yrs and below. This contrasted with the non TPE
group who had a higher mean age and with only 30% age
55 yrs and below.
Mean pleural fluid ADA was significantly higher in the
TPE group compared to non TPE group (100 ±35 IU/L
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vs 30 ± 37 IU/L, p < 0.001). There was no statistically
significant difference in pleural fluid ADA level between
the malignant, parapneumonic and others group, with
mean ADA 28 ± 49 IU/L, 40 ± 34 IU/L and 9 ± 6 IU/L
respectively. Only 1 patient was HIV positive (0.6%), 88
were HIV negative (55%) and HIV status was unknown
in 71 (44.4%).
There was no significant difference in pleural fluid ADA
level between genders. The Chinese appeared to have a
lower mean pleural ADA compared to the Indians and
other races, with ADA of 52 ± 48 IU/L, 94 ± 47 IU/L, and
110 ± 48 IU/L respectively. However, the difference in
ADA levels seen between the racial groups was likely due
to the lower proportion of TPE in Chinese compared to
the Indians and other races (36.9%, 80% and 87.5% respect-
ively). This explanation was supported by subgroup ana-
lyses of TPE and non TPE patients which did not reveal
any difference in ADA levels between the racial groups.
There was a moderate negative correlation between age
and pleural ADA, r = −0.621, p < 0.001, indicating that
pleural fluid ADA decreases with age. There was also a
moderate positive correlation between ADA and pleural
protein, r = 0.556, p < 0.001. Weakly positive correlations
were seen between pleural fluid ADA and pleural lactate
dehydrogenase (LDH), r = 0.427, p < 0.001, and pleural ab-
solute lymphocyte count, r = 0.314, p < 0.001. Peripheral
blood white cell counts and lymphocytes count had negli-
gible correlation with ADA with r = −0.177, p = 0.025 and
r = 0.201, p = 0.011 respectively.
We proceeded to analyse pleural fluid ADA levels in
the TPE and non TPE groups as shown in Table 2. In
the TPE group, those age > 55 yrs had significantly lower
pleural ADA levels than those ≤ 55 yrs. When analysed as
continuous variablesthere was weak negative correlation
between age and pleural fluid ADA with r = −0.281, p <
0.05. There was statistically significant correlation between
ADA, pleural protein and pleural LDH, but not with
pleural cell count and lymphocyte count.For non TPE
patients, there was significant negative correlation be-
tween ADA and age, and positive correlation with pleural
protein, LDH, cell count and absolute lymphocyte count.
Multivariate linear regression analysis was performed
and we found that the independent predictors of pleural
fluid ADA were age, pleural fluid protein, LDH, and ab-
solute lymphocyte count.
The receiver operating curve (ROC) for ADA was per-
formed for our study population. The area under curve
(AUC) was 0.941 (95% CI 0.899-0.983) (Figure 1). ADA
level of 45 IU/L would have a sensitivity of 93.8% and spe-
cificity of 82.5% for the diagnosis of TPE.We attempted to
determine the optimal pleural fluid ADA level for the
diagnosis of pleural TB for different age groups, taking age
cut-off of 55 years old. Age cut-off of 55 years was taken
because in clinical practice the suspicion of malignancy
and malignant pleural effusion increases with age, espe-
cially after age 50 years. Cut off of 55 years would divide
our study population into roughly equal numbers in the 2
age groups for comparison. Receiver operating character-
istics (ROC) curves were described for both age groups.
For patients age ≤ 55 yrs the ROC for ADA had AUC
of 0.887 (95% CI 0.775-0.999) (Figure 2). A pleural fluid
ADA of 72 IU/L would have a sensitivity of 95.1%, speci-
ficity of 87.5%, positive predictive value (PPV) of 95.1%
and negative predictive value (NPV) of 87.5% for the
diagnosis of TPE. For patients age > 55 yrs the ROC for
ADA had AUC of 0.959 (% CI 0.918-0.999) (Figure 3).
ADA of 26 IU/L would give a sensitivity of 94.7%, specifi-
city of 80.%, PPV of % and NPV of 97.8% for the diagnosis
of TPE. To improve specificity in this group of patients, a
higher ADA cut-off of 46 IU/L would give a specificity of
92.9% but a resultant lower sensitivity of 78.%.
Discussion
Our study suggests that patient and pleural fluid charac-
teristics need to be considered during interpretation of
pleural fluid ADA as it decreases with age and increases
Table 1 Baseline characteristics
All (n = 160) TPE (n = 80) Non TPE (n = 80)
Gender
Male 117 (73.1%) 58 (72.5%) 59 (73.8%)
Race
Chinese 103 (64.4%) 38 (47.5%) 65 (81.3%)
Malay 26 (16.3%) 16 (20%) 10 (12.5%)
Indian 15 (9.4%) 12 (15%) 3 (3.8%)
Others 16 (10%) 14 (17.5%) 2 (2.5%)
Mean age (years) 55 ± 21 44 ± 19 66 ± 17
Number of patients with age ≤ 55 years 85 (53.1%) 61 (76.3%) 24 (30%)
Number of patients with age > 55 years 75 (46.9%) 19 (23.8%) 56 (70%)
Mean ADA level (IU/L) 65 ± 51 100 ± 35 30 ± 37
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Figure 1 ROC curve for ADA.
Table 2 ADA analysis and correlation with study variables for different subgroups




Male 66 ± 50 p = 0.712 98 ± 37 p = 0.364 35 ± 42 P = 0.067




Chinese 52 ± 48 p < 0.001 95 ± 37 p = 0.306 27 ± 33 P = 0.121
Malay 73 ± 43 95 ± 36 38 ± 27
Indian 94 ± 47 113 ± 28 19 ± 18




Age ≤ 55 years 92 ± 47 P < 0.001 107 ± 33 P = 0.002 56 ± 57 P = 0.000
Age > 55 years 34 ± 34 79 ± 34 19 ± 15
Age corr coeff (r) r = −0.621 p < 0.001 r = −0.281 p = 0.011 r = −0.556 P = 0.000
Fluid
Corr coeff (r)
Protein r = 0.556 p < 0.001 r = 0.442 p < 0.001 r = 0.343 P = 0.02
LDH r = 0.427 p < 0.001 r = 0.473 p < 0.001 r = 0.836 P = 0.000
Cell count r = 0.237 p = 0.003 r = 0.160 p = 0.162 r = 0.573 P = 0.000
Lymphocytes r = 0.314 p < 0.001 r = 0.116 p = 0.305 r = 0.534 P = 0.000
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with pleural fluid protein. This is also, to the best of our
knowledge, one of the first few studies to determine the
ADA level for diagnosis of TPE according to different
age groups: 72 IU/L in those age ≤ 55 yrs and 26 IU/L in
those > 55 yrs.
This study adds to a relatively small number of papers
published on pleural fluid ADA performed on an Asian
population. Contrary to the study by Niwa et al. [9] which
showed an ADA level of only 42.9 IU/L in patients with
TPE and thus leading to a suspicion that ADA may be less
useful in Asians, patients with TPE in our study had mean
ADA of 100 IU/L which was similar to that reported by
Riantawan et al. [10].
Few studies have looked at the factors affecting pleural
ADA. In our study age had the strongest correlation with
pleural fluid ADA. We noted that the correlation between
age and ADA was much weaker when examined within
the subgroup of TPE patients. One possible explanation is
that the number of older patients aged > 55 years was rela-
tively small in the TPE group resulting in a less represen-
tative population. The relationship between age and ADA
demonstrated in our study was similar to that of Yeon
Figure 3 ROC curve for age > 55 years.
Figure 2 ROC curve for age ≤ 55 years.
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et al. from Korea [11]. Their study showed a significantly
higher ADA in patients with exudative pleural effusions
who were older than 65 yrs compared to those less than
65 yrs and the ADA cut-off for the diagnosis of TPE in the
older group was also much lower than for the younger
group (25.9 IU/L compared to 49.1 IU/L). Other authors
have also shown that young patients with TPE have a
much higher level of pleural fluid ADA. In a group of pa-
tients age ≤ 35 yrs the mean ADA level for those with TPE
was 111.1 IU/L, a similar figure to our study’s younger
TPE group [12]. Merino studied a paediatric population
(age < 18 yrs) with TPE and the mean ADA level obtained
was 73.8 IU/L with all but 2 patients (%) having ADA less
than 40 IU/L [13]. It may be possible that the decrease in
ADA with age does not occur as a continuum throughout
all ages but is evident only after a certain age.
Lee et al. [14] examined patients with non-tuberculous
lymphocytic effusions and found a fairly positive correlation
between ADA, pleural protein and LDH, similar to our
findings. In the study by Kashiwabara et al. [15] which con-
sisted of a larger proportion (%) of parapneumonic effusion
and mainly non-lymphocytic exudates, there was only posi-
tive correlation between ADA and LDH, but no significant
correlation with protein or age. Our study showed a poor
correlation between ADA and pleural cell count, and no
correlation with blood lymphocyte count. This was similar
to findings in other studies [10,14,16]. In fact,other authors
have shown that the sensitivity of ADA was not affected by
the CD4 count in pleural fluid and was still useful diagnos-
tically in HIV positive patients [10,16].
ADA has greatest activity in lymphoid tissues and is
responsible for the differentiation of lymphoid cells. There
are 2 isoenzymes, ADA1 and ADA2, with ADA2 found
only in monocytes and macrophages. The high total level
of ADA in tuberculous pleural effusion is due largely to
high ADA2 activity [17]. There is biologic plausibility of
the negative correlation between ADA and age, attributable
to the phenomenon of immunosenescence [18]. There is
increasing evidence that there is loss of immune function
in the elderly individual. We noted a weaker correlation be-
tween ADA and age in the TPE subgroup compared to the
overall study population. Apart from the possible effect due
to a small sample size of elderly TPE patients mentioned
earlier in the discussion, another postulation is that ageing
may affect monocytes and macrophages to varying degrees
compared to lymphocytes and subsequently a smaller effect
on ADA2 isozyme production, which is the predominant
isoenzyme in TPE. Pleural protein and LDH are both indi-
cators of the degree of pleural inflammation [1] and there
would be conceivably more activated lymphocytes and
ADA production in the presence of greater pleural inflam-
mation. Lee et al. [11] previously offered an explanation for
the lack of association between ADA and pleural cell count.
The standard ADA determination measures ADA activity
and not the absolute amount of enzyme present. ADA
activity may be dependent more on the pathologic stimulus
e.g. TB and rapidity of T lymphocyte proliferation, and not
on amount of lymphocytes present.
One clinical application of our study’s findings would
be the interpretation of pleural fluid ADA according to
patient characteristics. Pleural fluid ADA decreases with
age and therefore increases the number of ‘false negative’
results for diagnosis of TPE when a fixed cut-off level is
used in an older population compared to a younger popula-
tion. In our study, if the widely accepted standard ADA
cut-off level of 50 IU/L was used, 5 of the 19 patients (26.%)
with TPE in age group > 55 yrs would have a false negative
result. If the cut-off level of 26 IU/L was used, only 1 pa-
tient (5.%) would have a false negative ADA result. Simi-
larly, caution might have to be exercised in excluding a
diagnosis of TPE based on low ADA level if the pleural pro-
tein and LDH are also low.
Limitations of the study include its retrospective nature
but selection bias in this study would have been limited as
all patients in our institution investigated for pleural effu-
sion would have pleural fluid ADA performed. The etiolo-
gies of 3 of the pleural effusions were undetermined but
none had an eventual diagnosis of TPE.
Conclusions
In summary, we have demonstrated that pleural fluid ADA
is affected by age and pleural fluid protein. Using a lower
ADA level to exclude TPE in an older population can re-
duce the number of false negative results, and based on the
pleural fluid ADA results tuberculous treatment may po-
tentially be instituted early. Similarly, a higher ADA level in
younger patients would improve the accuracy of TPE diag-
nosis. Future large prospective studies would be needed to
validate the above findings.
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